438 related articles for article (PubMed ID: 27524242)
41. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
[TBL] [Abstract][Full Text] [Related]
42. Effect of lncRNA KCNQ1OT1 on autophagy and drug resistance of hepatocellular carcinoma cells by targeting miR-338-3p.
Zhong W; Dai Q; Huang Q
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):191-196. PubMed ID: 32538770
[TBL] [Abstract][Full Text] [Related]
43. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein.
Chen S; Liu R; Wang H; Liu Q
Pathol Res Pract; 2022 Sep; 237():154066. PubMed ID: 35985237
[TBL] [Abstract][Full Text] [Related]
46. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p.
He J; Sun M; Geng H; Tian S
Biol Cell; 2019 Feb; 111(2):39-50. PubMed ID: 30462844
[TBL] [Abstract][Full Text] [Related]
49. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
[TBL] [Abstract][Full Text] [Related]
50. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.
Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC
Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127
[TBL] [Abstract][Full Text] [Related]
51. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
52. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
[TBL] [Abstract][Full Text] [Related]
53. Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis.
Gao AM; Zhang XY; Hu JN; Ke ZP
Chem Biol Interact; 2018 Jan; 280():45-50. PubMed ID: 29191453
[TBL] [Abstract][Full Text] [Related]
54. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
Jiang C; Long J; Liu B; Xie X; Kuang M
Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
[TBL] [Abstract][Full Text] [Related]
55. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
56. Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.
He C; Sun XP; Qiao H; Jiang X; Wang D; Jin X; Dong X; Wang J; Jiang H; Sun X
Cancer Sci; 2012 Mar; 103(3):528-34. PubMed ID: 22145922
[TBL] [Abstract][Full Text] [Related]
57. Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.
Yang SL; Liu LP; Niu L; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
Oncotarget; 2016 Jun; 7(23):34571-81. PubMed ID: 27119229
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
59. Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.
Ren W; Guan W; Zhang J; Wang F; Xu G
Aging (Albany NY); 2019 Apr; 11(7):2151-2176. PubMed ID: 30982780
[TBL] [Abstract][Full Text] [Related]
60. MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis.
Liu H; Shi C; Deng Y
Mol Cell Biochem; 2020 Mar; 466(1-2):25-34. PubMed ID: 31933110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]